Suppr超能文献

T 细胞急性淋巴细胞白血病中的 PTEN 微缺失是由非法 RAG 介导的重组事件引起的。

PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.

机构信息

Department of Pediatric Oncology/Hematology, Erasmus University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands;

Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal;

出版信息

Blood. 2014 Jul 24;124(4):567-78. doi: 10.1182/blood-2014-03-562751. Epub 2014 Jun 5.

Abstract

Phosphatase and tensin homolog (PTEN)-inactivating mutations and/or deletions are an independent risk factor for relapse of T-cell acute lymphoblastic leukemia (T-ALL) patients treated on Dutch Childhood Oncology Group or German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia protocols. Some monoallelic mutated or PTEN wild-type patients lack PTEN protein, implying that additional PTEN inactivation mechanisms exist. We show that PTEN is inactivated by small deletions affecting a few exons in 8% of pediatric T-ALL patients. These microdeletions were clonal in 3% and subclonal in 5% of patients. Conserved deletion breakpoints are flanked by cryptic recombination signal sequences (cRSSs) and frequently have non-template-derived nucleotides inserted in between breakpoints, pointing to an illegitimate RAG recombination-driven activity. Identified cRSSs drive RAG-dependent recombination in a reporter system as efficiently as bona fide RSSs that flank gene segments of the T-cell receptor locus. Remarkably, equivalent microdeletions were detected in thymocytes of healthy individuals. Microdeletions strongly associate with the TALLMO subtype characterized by TAL1 or LMO2 rearrangements. Primary and secondary xenotransplantation of TAL1-rearranged leukemia allowed development of leukemic subclones with newly acquired PTEN microdeletions. Ongoing RAG activity may therefore actively contribute to the acquisition of preleukemic hits, clonal diversification, and disease progression.

摘要

磷酸酶和张力蛋白同源物(PTEN)失活突变和/或缺失是荷兰儿童肿瘤组或德国儿童急性淋巴细胞白血病合作研究组方案治疗的 T 细胞急性淋巴细胞白血病(T-ALL)患者复发的独立危险因素。一些单等位基因突变或 PTEN 野生型患者缺乏 PTEN 蛋白,这意味着存在其他 PTEN 失活机制。我们表明,在 8%的儿科 T-ALL 患者中,少数外显子的小缺失导致 PTEN 失活。这些微缺失在 3%的患者中是克隆性的,在 5%的患者中是亚克隆性的。保守的缺失断点两侧是隐蔽的重组信号序列(cRSSs),并且在断点之间经常插入非模板衍生的核苷酸,表明存在非法 RAG 重组驱动的活性。鉴定出的 cRSSs 在报告系统中有效地驱动 RAG 依赖性重组,就像侧翼 T 细胞受体基因座基因片段的真正 RSSs 一样。值得注意的是,在健康个体的胸腺细胞中也检测到了等效的微缺失。微缺失与 TALLMO 亚型强烈相关,该亚型的特征是 TAL1 或 LMO2 重排。TAL1 重排白血病的原发性和继发性异种移植允许具有新获得的 PTEN 微缺失的白血病亚克隆的发展。因此,持续的 RAG 活性可能积极促进前白血病命中的获得、克隆多样化和疾病进展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验